CorMedix, Inc. (CRMD)
7.03
-0.05
(-0.71%)
USD |
NASDAQ |
Feb 20, 16:00
7.03
0.00 (0.00%)
After-Hours: 20:00
CorMedix SG&A Expense (Quarterly) : 36.64M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Pfizer Inc. | 4.162B |
| Amicus Therapeutics, Inc. | 117.08M |
| Arcutis Biotherapeutics, Inc. | 62.40M |
| ANI Pharmaceuticals, Inc. | 76.66M |
| Castle Biosciences, Inc. | 55.91M |